Tech Company Financing Transactions
Emulate Funding Round
Emulate closed a $700 million funding round on 9/17/2026. Investors included Index Ventures, Lightspeed Venture Partners and private investors.
Transaction Overview
Company Name
Announced On
9/17/2026
Transaction Type
Venture Equity
Amount
$700,000,000
Round
Undisclosed
Investors
Index Ventures (Lead Investor)
Lightspeed Venture Partners (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
27 Drydock Ave.
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Website
Email Address
Overview
Official website of Emulate, Inc. Based on our Organs-on-Chips technology, we have created a new living system that emulates human biology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Corbett
Chief Financial Officer
Scott Kantor
Chief Scientific Officer
Lorna Ewart
Chief Technical Officer
Daniel Levner
Founder
Donald Ingber
Vice President
Chris Hinojosa
Vice President
Kyung Jang
VP - General Counsel
Larry Weiss
VP - Human Resources
Sandy Lazzari
VP - Human Resources
Stacy Perro
VP - Marketing
Jenn Perkins
VP - Product Management
Luke Dimasi
VP - Regulatory Affairs
Ernie Ansah
VP - Sales
Stuart Gibb
Browse more venture capital transactions:
Prev: 9/17/2026: MIND venture capital transaction
Next: 9/17/2026: Chemify venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs